The importance of pre-treatment haemoglobin level in inoperable non-small cell lung carcinoma treated with radical radiotherapy.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 12865181.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The purpose of this study was to evaluate the prognostic significance of the pre-treatment haemoglobin level among patients with inoperable non-small cell lung carcinoma (NSCLC) treated with definitive radiotherapy with regard to loco-regional tumour control (LC) and overall survival (OS). Patients (n=526) with previously untreated NSCLC, stages I-IIIb, WHO-performance status of 0-2 were eligible. All patients were treated with definitive external irradiation (60 Gy in 6 weeks). In the multivariate analysis, the pre-treatment haemoglobin level was an independent prognostic factor for both loco-regional control and the overall survival. pre-treatment haemoglobin levels are strongly associated with loco-regional tumour control and the overall survival.
Medical subject headings
- Anemia
- Carcinoma, Non-Small-Cell Lung
- Hemoglobins
- Lung Neoplasms